You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 25, 2022

Myanmar Indirectly Bans Exports of Value-Added Beans, Corn, and Sesame by Foreign Companies

On July 27, 2022, Myanmar’s Ministry of Commerce (MOC) issued Newsletter No. 8/2022 to effectively ban foreign companies and foreign joint ventures from exporting value-added beans, corn, and sesame.

This newsletter repealed Newsletter No. 2/2020, which had prescribed the criteria for beans, corn, and sesame to be considered “value-added” crops. These criteria had to be fulfilled in order for these commodities to be exported in accordance with Notification No. 24/2019, which had permitted foreign companies and foreign joint ventures to purchase seven categories of commodities from local manufacturers for export, subject to certain terms and conditions. These include:

  • Meat and fish;
  • Value-added crops;
  • Pulp and paper;
  • Seeds;
  • Refined metals;
  • Semi-finished or finished valued-added fruit products; and
  • Timber-based furniture.

With the repeal of the conditions in Newsletter No. 2/2020, foreign exporters are left with no reference criteria for how to achieve “value-added” status for beans, corn, and sesame, and thus will not be able to submit a complete application for the necessary export license. However, exportation of the other items in the list above remains unaffected and open to foreign exporters who meet the applicable requirements.

The MOC explained their decision to revoke the permitted criteria by noting that some foreign companies were not actually producing beans, corn, and sesame that fulfilled the criteria for value-added status as laid out in Newsletter No. 2/2020, but were falsely exporting their goods as “value-added crops.” The revocation of the export criteria for beans, corn, and sesame took immediate effect.

For more details on these export restrictions, or on any aspect of importation and exportation regulations in Myanmar, please contact Tilleke & Gibbins at [email protected].

RELATED INSIGHTS​ 

August 24, 2015
Expanding waistlines and increasing health awareness have given rise to a consumer culture infatuated with well-being, not only in Thailand but all over the world. For producers, this means intense pressure to create healthy or healthier versions of their products. For the government—specifically the Thai Food and Drug Administration (FDA)—this means an obligation to implement and enforce stricter regulations on food and nutrition.
July 14, 2015
The latest edition of the PLC Life Sciences Multi-jurisdictional Guide  provides a Q&A-style analysis of the current regulatory framework surrounding the life sciences industry. Lawyers at Tilleke & Gibbins authored the Vietnam chapter of the guide, which covers national healthcare, regulation of medicinal product prices, clinical trials, manufacturing, sales and marketing, advertising, data protection, packaging and labeling, product liability, patents, trademarks, and competition law.Practical Law Company is a leading provider of legal resources.
July 14, 2015
Practical Law Company has published the latest edition of the PLC Life Sciences Multi-jurisdictional Guide, a Q&A-style guide which provides country-specific analysis of the current regulatory framework surrounding the life sciences industry. Tilleke & Gibbins authored the Thailand chapter of this guide, which looks at pricing and state funding, manufacturing, marketing, clinical trials, advertising, labeling, product recall and liability, patents, trademarks, competition law, patent licensing, generic entry, abuse of dominance, and parallel imports.
June 29, 2015
Kien Trung Trinh, senior attorney-at-law, and Tu Ngoc Trinh, attorney-at-law, in Tilleke & Gibbins’ Hanoi office, have co-authored the Vietnam chapter of The International Comparative Legal Guide to: Pharmaceutical Advertising 2015 (12th edition), a Q&A-style guide that provides practical, cross-border insight into pharmaceutical advertising across 35 jurisdictions. The Vietnam chapter covers the following main topics: